Fortis Healthcare share news, announcements and annual reports

NSE: FORTISBSE: 532843Healthcare ServicesMid Cap

Fortis Healthcare Limited · Formerly Fortis Healthcare (India) · Face value ₹10 · Listed May 2007

₹768.15₹13.25 (1.76%)BSE ₹769.80

Share price at the NSE close on 30 Oct 2026. Previous close ₹754.90.

30 Oct: open ₹754.90, high ₹768.15, low ₹745.00

52-week range of traded prices to 30 Oct 2026

₹704.95Low, 23 Oct 2026₹1,057.45High, 30 Oct 2025

Next results date: the board meets on 5 Nov 2026 to consider: financial results and other business matters. The notice · Results calendar

Market cap: ₹57,992 Cr156th largest listed
P/E: 55.34
P/B: 5.86
Dividend yield: 0.13%
ROE: 11.1%
ROCE: 12.7%
Debt to equity: 0.28
Volume, NSE: 14,56,10356.9% delivered

Fortis Healthcare board and management

69 filed, newest first. Page 1 of 2.

Dec 2025
- 19 Dec · Management
  Appointment of Mr. Mohd Shahazwan Bin Mohd Harris as Other of the company w.e.f. December 19, 2025.
Sep 2025
- 9 Sep · Management
  Change in Director(s) of the company.
Aug 2025
- 11 Aug · Management
  Appointment of M/s Neelam Gupta & Associates as Other of the company
Jun 2025
- 27 Jun · Management
  Change in Director(s) of the company.
Oct 2024
- 9 Oct · Management
  Change in Auditors of the company.
Sep 2024
- 23 Sep · Management
  Appointment of Mr Indrajit Banerjee as Chairman of the company w.e.f. October 01, 2024.
- 23 Sep · Management
  Change in Director(s) of the company.
Aug 2024
- 6 Aug · Management
  Resignation of Independent director.
- 6 Aug · Management
  Change in Auditors of the company.
- 6 Aug · Management
  Appointment of M/s. B S R & Co. LLP as Other of the company w.e.f. August 06, 2024.
- 6 Aug · Management
  Change in Management
- 6 Aug · Management
  Change in Director(s) of the company.
Jul 2024
- 5 Jul · Management
  Change in Director(s) of the company.
Jun 2024
- 11 Jun · Management
  Change in Management
May 2024
- 23 May · Management
  Change in Auditors of the company.
Mar 2024
- 13 Mar · Management
  Change in Management
Feb 2024
- 9 Feb · Management
  Change in Management
Jan 2024
- 12 Jan · Management
  ("Listing Regulations") read with SEBI Circular dated July 13, 2023, this is to inform you Mr. Mayank Bhargava Chief Information & Digital Officer of the Company, has resigned with effect from January 12, 2024 (from the close of business hours).The detailed disclosure as required under Regulation 30 of the Listing Regulations read with SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023 is enclosed as Annexure-A.Further, the copy of his resignation letter is also enclosed as Annexure- B.This is for your information and record.
Nov 2023
- 10 Nov · Management
  Appointment of Mr Prem Kumar Nair as Non- Executive Director of the company w.e.f. November 10, 2023.
Oct 2023
- 7 Oct · Management
  Pursuant to letter dated October 6, 2023 received from Northern TK Venture Pte. Ltd. ("Promoter of the Company") intimating about withdrawal of nomination of Mr. Joerg Ayrle (DIN: 09128449) from the Board of the Company, Mr. Joerg Ayrle has ceased to be the Non-Executive & Non-Independent Director of the Company with effect from October 2, 2023.
Sep 2023
- 13 Sep · Management
  Appointment of Mr Ashok Pandit as Non- Executive Director of the company w.e.f. September 13, 2023.
- 1 Sep · Management
  Resignation of Mr Heng Joo Joe Sim as Non- Executive Director of the company w.e.f. September 01, 2023.
Aug 2023
- 31 Aug · Management
  ("Listing Regulations") read with SEBI Circular dated July 13, 2023, this is to inform you Mr. Rajiv Puri- Head Risk and Internal Audit of the Company, has resigned with effect from August 31, 2023 (from the close of business hours).The detailed disclosure as required under Regulation 30 of the Listing Regulations read with SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023 is enclosed as Annexure-A.Further, the copy of his resignation letter is also enclosed as Annexure- B.
May 2023
- 4 May · Management
  Change in Director(s) of the company.
Mar 2023
- 28 Mar · Management
  Appointment of Mr Mehmet Ali Aydinlar as Non- Executive Director of the company w.e.f. March 28, 2023.
- 28 Mar · Management
  Resignation of Mr Farid Bin Mohamed Sani as Non- Executive Director of the company w.e.f. March 28, 2023.
- 28 Mar · Management
  Change in Director(s) of the company.
Feb 2023
- 23 Feb · Management
  Resignation of Mr Kelvin Loh Chi-Keon as Non- Executive Director of the company w.e.f. February 22, 2023.
May 2022
- 26 May · Management
  Pursuant to provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company at its meeting held on May 25, 2022 have, inter-alia, considered and approved the Re-appointment of Mr. Ravi Rajagopal, Ms. Suvalaxmi Chakraborty and Mr. Indrajit Banerjee as Independent Directors of the Company, subject to approval of the shareholders, for the second term of upto 5 years. Further, the detailed disclosure as required under Regulation 30 of the Listing Regulations read with SEBI Circular No. CIR/ CFD /CMD/4/2015 dated September 9, 2015 is enclosed.
- 26 May · Management
  Pursuant to provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company at its meeting held on May 25, 2022 have, inter-alia, considered and approved the Re-appointment of Mr. Ravi Rajagopal, Ms. Suvalaxmi Chakraborty and Mr. Indrajit Banerjee as Independent Directors of the Company, subject to approval of the shareholders, for the second term of upto 5 years. Further, the detailed disclosure as required under Regulation 30 of the Listing Regulations read with SEBI Circular No. CIR/ CFD /CMD/4/2015 dated September 9, 2015 is enclosed.
Apr 2022
- 1 Apr · Management
  ("Listing Regulations"), this is to inform you that the Board of Directors of the Company at its meeting held on March 31, 2022 have, inter-alia, considered the following:a) Noting of the resignation of Mr. Sumit Goel from the position of Company Secretary & Compliance Officer of the Company with effect from April 4, 2022 (close of business hours). b) Approved the appointment of Mr. Murlee Manohar Jain as Company Secretary & Compliance Officer of the Company with effect from April 5, 2022.Further, the detailed disclosure as required under Regulation 30 of the Listing Regulations read with SEBI Circular No. CIR/ CFD /CMD/4/2015 dated September 9, 2015 is enclosed as Annexure-A.This is for your information and record.
- 1 Apr · Management
  ("Listing Regulations"), this is to inform you that the Board of Directors of the Company at its meeting held on March 31, 2022 have, inter-alia, considered the following:a) Noting of the resignation of Mr. Sumit Goel from the position of Company Secretary & Compliance Officer of the Company with effect from April 4, 2022 (close of business hours). b) Approved the appointment of Mr. Murlee Manohar Jain as Company Secretary & Compliance Officer of the Company with effect from April 5, 2022.Further, the detailed disclosure as required under Regulation 30 of the Listing Regulations read with SEBI Circular No. CIR/ CFD /CMD/4/2015 dated September 9, 2015 is enclosed as Annexure-A.This is for your information and record.
Jul 2021
- 16 Jul · Management
  Change in Director(s) of the company.
Jun 2020
- 29 Jun · Management
  Appointment of Mrs Shailaja Chandra as Non- Executive Independent Director of the company w.e.f. Jun 28, 2020.
- 4 Jun · Management
  Change in Director(s) of the company.Dear Sir(s),In compliance of Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, this is to inform you that Board of Directors of the Company has approved appointment of Mr. Dilip Kadambi (DIN:02148022), as an Additional Director (Non-Executive) of the Company with effect from June 4, 2020. He will hold the office up to the ensuing Annual General Meeting and will be regularized subject to the approval of the shareholders. Brief Profile of Mr. Dilip Kadambi is attached as Annexure 1. Further, there is no inter-se relationship between Mr. Dilip Kadambi and other Directors. Mr. Dilip Kadambi has declared that he is not debarred from accessing the capital markets and / or restrained from holding any position / office of Director in a Company pursuant to order of SEBI or any other such authority.Further, Mr. Low Soon Teck (DIN: 01880497), Non-Executive Director of the Company, has resigned from the Directorship of the Company with effect from June 4, 2020.This is for your information and records please.
Dec 2019
- 30 Dec · Management
  Appointment of Mr Dr Farid Bin Mohamed Sani as Non- Executive Director of the company w.e.f. December 30, 2019.The detailed disclosure in this regard is attached for your reference.
- 2 Dec · Management
  Change in Director(s) of the company.In compliance of Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, this is to inform you that Mr. Chintamani Aniruddha Bhagat (DIN: 07282200), Non-Executive Director of the Company, has resigned from the Directorship of the Company with immediate effect.Reason for resignation: - Mr. Bhagat has stepped down from Board of IHH Healthcare Berhad ( IHH ). Consequently, stepping off from all Boards where he was representing IHH. Accordingly, he has stepped off from Fortis Board.This is for your information and records please.
Nov 2019
- 26 Nov · Management
  Change in Director(s) of the company.In compliance of Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, this is to inform you that Board of Directors of the Company has approved appointment of Mr. Sim Heng Joo Joe (DIN:08033111) ( Mr. Joe ) as an additional director (Non-Executive and Non-Independent) of the Company with immediate effect. He will hold the office up to the next Annual General Meeting and will be regularized subject to the approval of the shareholders. He is not related to any of the existing directors. Brief Profile of Mr. Joe is attached herewith. Mr. Joe declared that, he is not debarred from accessing the capital markets and / or restrained from holding any position / office of director in a company pursuant to order of SEBI or any other such authority.This is for your information and records please.
Oct 2019
- 25 Oct · Management
  Change in Director(s) of the company.In compliance of Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, this is to inform you that Dr Chan Boon Kheng (DIN: 08268826), Non-Executive Director of the Company, has resigned from directorship of the Company effective from October 31, 2019.This is for your information and records please.
Sep 2019
- 28 Sep · Management
  Change in Director(s) of the company.In compliance of Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, this is to inform you that Board of Directors of the Company has approved appointment of Dr. Kelvin Loh Chi-Keon (DIN:08515101) as an additional director (Non-Executive and Non-Independent) of the Company with immediate effect. He will hold the office up to the next Annual General Meeting and will be regularized subject to the approval of the shareholders. He is not related to any of the existing directors. Brief Profile of Dr. Loh is attached herewith and marked as Annexure 1. Dr. Loh declared that, he is not debarred from accessing the capital markets and / or restrained from holding any position / office of director in a company pursuant to order of SEBI or any other such authority.Further, Dr. See Leng Tan, Non-Executive Director of the Company, has resigned from directorship of the Company effective from September 27, 2019.This is for your information and records please.
Feb 2019
- 7 Feb · Management
  Appointment of Mr Ashutosh Raghuvanshi as Chief Executive Officer of the company w.e.f. March 18, 2019.
Dec 2018
- 29 Dec · Management
  Change in Auditors of the company.This is to inform that the pursuant to the issuance of 235,294,117 equity shares to Northern TK ventures Pte Limited, a subsidiary of IHH, IHH has become the largest shareholder in the Company. Further, post induction of additional nominee directors of IHH on the Boards of the company, IHH prefers to align its auditors on a group wide basis. This may lead to streamlining the audit process and also bring in efficiencies from a cost and time perspective.The aforesaid matter was discussed with the Statutory Auditors of the Company,- Deloitte Haskins and Sells LLP. After due consideration, Statutory Auditors have tendered their resignation w.e.f. December 28, 2018.
Nov 2018
- 8 Nov · Management
  Resignation of Mr Bhavdeep Singh, as Chief Executive Officer of the company w.e.f. November 08, 2018.Dear Sir(s),In compliance of Regulation 30 and Para A of Part A of Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, we wish to inform you that Mr. Bhavdeep Singh, Chief Executive Officer, has resigned from his position by communication dated November 08, 2018. The Board of Directors of the Company has considered and accepted his resignation. At the request of the Board, Mr. Singh has agreed to continue in his current capacity till such time his succession planning is crystallised.The Chairman, on behalf of the Board, has placed on record their deep appreciation for the leadership provided by Mr. Singh in steering the organisation over the past three and a half years. In particular, during the past two years of high turbulence, his tenacity and perseverance have been instrumental in keeping the organisation steady through a very challenging period in the company's history.This is for your information and records please.
Aug 2018
- 30 Aug · Management
  Resignation of Mr Gagandeep Singh Bedi as Chief Financial Officer of the company w.e.f. September 30, 2018.
Jun 2018
- 1 Jun · Management
  Appointment of Mr Ravi Rajagopal as Chairman of the company w.e.f. Jun 01, 2018.This is to inform that the Board of Directors today, by circulation, appointed Mr. Ravi Rajagopal, Non-Executive Independent Director as the Chairman of the Board with immediate effect.The same may kindly be read in compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.This is for your information and records please.
May 2018
- 24 May · Management
  Change in Director(s) of the company.This is in continuation to our letter(s) Ref. No. FHL/SEC/STEX/RR/2018-19 dated dated May 23, 2018 regarding submission of voting results of Extra-ordinary general meeting and in terms of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform that the following changes took place in the constitution of the Board w.e.f. May 22, 2018: Ms. Suvalaxmi Chakraborty (DIN: 00106054) was appointed as an Independent Director of the Board; Mr. Ravi Rajagopal (DIN: 00067073) was appointed as an Independent Director of the Board; Mr. Indrajit Banerjee (DIN: 00106054) was appointed as an Independent Director of the Board; Dr. Brian William Tempest (DIN: 00101235) was removed from the Board of the Company.The brief profiles of the directors appointed is given in Annexure 1.
- 21 May · Management
  Change in Director(s) of the company.Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that Ms. Sabina Vaisoha, Non-Executive Independent Director (DIN: 00207306) has tendered her resignation from the directorship of the Company w.e.f. May 20, 2018 due to personal reasons. You are requested to take the same on records.
- 20 May · Management
  Change in Director(s) of the company.Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that Mr. Harpal Singh, Non-Executive Director (DIN: 00078224) has tendered his resignation from the directorship of the Company w.e.f. May 20, 2018 due to personal reasons. You are requested to take the same on records.
- 20 May · Management
  Change in Director(s) of the company.Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that Lt. Gen. Tejinder Singh Shergill, Non-Executive Independent Director (DIN: 00940392) has tendered his resignation from the directorship of the Company w.e.f. May 20, 2018 due to personal reasons. You are requested to take the same on records.
Mar 2018
- 22 Mar · Management
  Resignation of Mr Pradeep Ratilal Raniga as Non- Executive Independent Director of the company w.e.f. March 22, 2018.

Fortis Healthcare board and management

Dec 2025

Sep 2025

Aug 2025

Jun 2025

Oct 2024

Sep 2024

Aug 2024

Jul 2024

Jun 2024

May 2024

Mar 2024

Feb 2024

Jan 2024

Nov 2023

Oct 2023

Sep 2023

Aug 2023

May 2023

Mar 2023

Feb 2023

May 2022

Apr 2022

Jul 2021

Jun 2020

Dec 2019

Nov 2019

Oct 2019

Sep 2019

Feb 2019

Dec 2018

Nov 2018

Aug 2018

Jun 2018

May 2018

Mar 2018